www.fdanews.com/articles/69349-archus-orthopedics-receives-european-marketing-approval
Archus Orthopedics Receives European Marketing Approval
March 2, 2005
Archus Orthopedics has announced that it has received CE Mark approval of its Total Facet Arthroplasty System (TFAS). The CE Mark allows the company to freely market the device in any European Union member country. The TFAS is a novel, patented spinal implant designed to treat spinal stenosis, a condition in which degenerative changes in the facet joints result in compression of spinal nerves producing neurological symptoms in the legs.
ArriveNet (http://press.arrivenet.com/bus/article.php/603452.html)